• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,628.48 -303.12
(-0.61%)
Dow Jones
7,359.75 -26.37
(-0.36%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.67 -0.51
(-0.53%)
EUR-INR
111.19 -0.10
(-0.09%)
GBP-INR
128.70 -0.19
(-0.14%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Aarti Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524348
INE767A01016
147.0110661
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AARTIDRUGS
19.55
3630.26
EPS(TTM)
Face Value()
Div & Yield %
20.35
10
0.25
 

acs technologies ltd
Purple Finance reports standalone net profit of Rs 0.02 crore in the March 2026 quarter
Apr 22,2026
Net profit of Purple Finance reported to Rs 0.02 crore in the quarter ended March 2026 as against net loss of Rs 3.92 crore during the previous quarter ended March 2025. Sales rose 172.00% to Rs 17.00 crore in the quarter ended March 2026 as against Rs 6.25 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 6.44 crore in the year ended March 2026 as against net loss of Rs 15.55 crore during the previous year ended March 2025. Sales rose 223.71% to Rs 47.65 crore in the year ended March 2026 as against Rs 14.72 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales17.006.25 172 47.6514.72 224
OPM %26.65-43.20 -10.75-89.33 -
PBDT1.01-4.52 LP -6.86-18.75 63
PBT0.43-5.02 LP -9.13-20.52 56
NP0.02-3.92 LP -6.44-15.55 59